NLRP1 and prostate adenocarcinoma: Additionally, the decreased NLRP1 expression level was linked to adverse PFS in ACC, CHOL, and HNSC, while increased NLRP1 expression was associated with detrimental PFS in LGG, PRAD, and STAD.